HALO logo
halo search icon
Savara, Inc.

US$5.08

Price Change Indicator
0.36 (7.63%)
Savara, Inc.
SVRA · NAS

Savara, Inc.

Start Trading SVRA for Free

US$5.08

Price Arrow0.36 (7.63%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Savara, Inc. Overview

SVRA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About SVRA

icon
icon

Telephone

1.512.614.1848

icon

Address

Suite 300, 1717 Langhorne Newtown Road, One Summit Square, Langhorne, PA 19047

Description

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

SVRA Price Chart

Key Stats

Market Cap

US$967.26M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.89 - 7.01

Trade Value (12mth)

US$2,051,608.00

1 week

-6.16%

1 month

-10.61%

YTD

-16.31%

1 year

62.2%

All time high

9415.00

Key Fundamentals

EPS 3 yr Growth

114.00%

EBITDA Margin

0.00%

Operating Cashflow

-$101m

Free Cash Flow Return

-46.90%

ROIC

-55.10%

Interest Coverage

0.00

Quick Ratio

11.80

Other Data

Shares Outstanding (Fully Diluted)

253m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SVRA Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
28 January 26
10 January 26
10 January 26

SVRA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.33-0.48-0.53locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.33-0.48-0.53locklocklock
Growth
 %locklocklocklock-32.6-46.1-10.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Savara, Inc. (SVRA:NAS)?
Halo FAQ
The current share price of Savara, Inc. (SVRA:NAS) is USD$5.08.
What is the 52-week high share price for Savara, Inc. (SVRA:NAS)?
Halo FAQ
The 52-week high share price for Savara, Inc. (SVRA:NAS) is USD$7.01.
What is the 52-week low share price for Savara, Inc. (SVRA:NAS)?
Halo FAQ
The 52-week low share price for Savara, Inc. (SVRA:NAS) is USD$1.89.
What is the dividend yield for Savara, Inc. (SVRA:NAS)?
Halo FAQ
Savara, Inc. (SVRA:NAS) does not pay a dividend.
What was Savara, Inc. (SVRA:NAS) last dividend payment?
Halo FAQ
Savara, Inc. (SVRA:NAS) does not pay a dividend.
What is the franking level for Savara, Inc. (SVRA:NAS)?
Halo FAQ
Savara, Inc. (SVRA:NAS) has a franking level of 0.00%.
In which sector is Savara, Inc. (SVRA:NAS) classified?
Halo FAQ
Savara, Inc. (SVRA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial